Development of approximate formula for LDL-chol, LDL-apo B and LDL- chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL

Atherosclerosis

Volumn 138, Issue 2, 1998, Pages 289-299

  Hattori, Yuichi ^c   Suzuki, Masaaki ^a   Tsushima, Motoo ^a   Yoshida, Masami ^a   Tokunaga, Yoko ^a   Wang, Ying ^a   Zhao, Di ^a   Takeuchi, Makoto ^d   Hara, Yasushi ^a   Ikeda Ryomoto, Kayoko ^a   Ikebuchi, Motoyoshi ^a   Kishioka, Hiroshi ^e   Mannami, Toshifumi ^b   Baba, Syunnroku ^b   Harano, Yutaka ^a  

^a Metab and Clin Nutr Natl C   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c KONAN UNIVERSITY   (Japan)

^d KOBE CITY COLLEGE OF TECHNOLOGY   (Japan)

^e Kyowa Medix KK   (Japan)

Author keywords

Hyperapobetaliproprotein; LDL apo B; LDL chol; Small dense LDL

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

APOLIPOPROTEINS B; ARTERIOSCLEROSIS; CHOLESTEROL, LDL; HUMANS; HYPERLIPOPROTEINEMIAS; LIPOPROTEINS, LDL; MODELS, BIOLOGICAL;

EID: 0032102116     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00034-3     Document Type: Article

References (19)

1. Castelli WP, Garrison RJ, Wilson PWP, Abbott RD, Kalousdian S, Kannel WB Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Heart Study 1986. J Am Med Assoc. 256:1986;2835.
2. Zhao X-Q, Brown BG, Hillger L, Sacco D, Bisson B, Fisher L, Albers JJ Effects of intensive lipid-lowering therapy on the coronary arteries of asymptomatic subjects with elevated apolipoprotein B. Circulation. 88:1993;2744.
3. Sniderman AD, Wolfson C, Teng B, Franklin FA, Bachorik PS, Kwiterovich PO Jr. Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med. 97:1982;833.
4. Harano Y, Kageyama A, Nakao Y, Hara Y, Suzuki M, Sato A, Ikebuchi M, Shinozaki K, Tsushima M Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects. Diabetes. 45(Suppl):1996;S31.
5. Lanhdenperä S, Syvänne M, Kahri J, Taskinen M-R Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease - importance of serum triglycerides. Diabetologia. 39:1996;453.
6. Harano Y, Nakao Y, Kageyama A, Suzuki M, Hirose J, Asakura Y, Sato A, Komatsu R, Tsusima M, Yamamoto A. A contribution of hyperinsulinemia and hyperglycemia to lipoprotein disorder in obesity. In: Oomura Y, Tarui S, Inoue S, Shimazu T, editors. Progress in Obesity Research. London: Libby, 1990:299-302.
7. Schwandt P The triglyceride controversy - a review of the data. Eur Heart J. 11(Suppl H):1990;43.
8. Yokota C, Nonogi H, Miyazaki S, Goto Y, Haze Y, Hara Y, Shinozaki K, Ikebuchi M, Suzuki M, Harano Y Lipoprotein analyses in patients with stable angina and acute coronary syndrome. Int J Cardiol. 57:1996;161.
9. Kwiterovich PO Jr., Coresh J, Bachorik PS Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged ≤50 years) and women (aged ≤60 years) with coronary artery disease. Am J Cardiol. 71:1993;631.
10. Hatch FT, Lee RS Practical method for plasma lipoprotein analysis. Adv Lipid Res. 6:1968;1.
11. Ryomoto KI, Suzuki M, Tsushima M, Yamamoto A, Harano Y Effects of simvastatin on the number and composition of apoprotein B-containing lipoproteins in hypercholesterolemia: analysis of apoprotein B in each lipoprotein fraction by highly sensitive latex method. Endocr J. 43:1996;469.
12. Harano Y Highly sensitive apo B assay and its clinical significance. Jpn J Clin Pathol. 38:1990;861.
13. Harano Y, Kojima H, Nakano T, Harada M, Kashiwagi A, Nakajima T, Hidaka TH, Ohtsuki T, Suzuki T, Tamura A, Fujii T, Nishimura T, Ohtaka T, Shigeta Y Homozygous hypobetalipoproteinemia with spared chylomicron formation. Metabolism. 38:1989;1.
14. Freund J, Little RC. SAS System for Regression. 2nd ed. Cary, NC: SAS Institute, 1992.
15. Schlotzhauer SD, Little RC. SAS System for Elementary Statistical Analysis. Cary, NC: SAS Institute, 1991.
16. Friedewald T, Levy RI, Fredrickson DS Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499.
17. Kwiterovich PO Jr, Motevalli M, Woodford FP, Davignon J, Sniderman A, editors. Hyperapo B - An Update. Atherosclerosis X. Amsterdam: Elsevier, 1995:966-971.
18. Ikeda K, Suzuki M, Ikebuchi M, Hara Y, Tsushima M, Yamamoto A, Harano Y Hyperbetalipoproteinemia with small low-density lipoprotein, a characteristic disorder of lipoprotein in essential hypertension. J Diabetes Complications. 9:1995;227.
19. Sato A, Kanazawa A, Hasegawa M, Asakura Y, Yokota C, Suzuki M, Tusima M, Kuriyama Y, Sawada T, Yamaguchi T, Kobayashi M, Harano Y. Lipoprotein disorder in brain infarction and hemorrhage. Int J Clin Lab Res 1998 (in press).